Clinical significance of human cytomegalovirus viruria and the effect of antiviral therapy in hematopoietic stem cell transplant recipients

Clinical significance of human cytomegalovirus viruria and the effect of antiviral therapy in hematopoietic stem cell transplant recipients

Background: Cytomegalovirus (CMV) causes life-threatening infections in immunocompromised host. The clinical significance of asymptomatic CMV viruria in patients receiving hematopoietic stem cell transplantation (HSCT) remains unclear. This study aims to clarify whether antiviral therapy is associat...

Full description

Bibliographic Details
Main Authors:	Wei-Lu, Su-Jung Chen, Shiang-Fen Huang, Yu-Jiun Chan, Fu-Der Wang, Hsin-Pai Chen
Format:	Article
Language:	English
Published:	Elsevier 2019-06-01
Series:	Journal of Microbiology, Immunology and Infection
Online Access:	http://www.sciencedirect.com/science/article/pii/S1684118217302025

Similar Items

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
by: Lauren Stern, et al.
Published: (2019-05-01)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
by: Ndeye Soukeyna Diop, et al.
Published: (2021-06-01)

High-level viruria as a screening tool for BK virus nephropathy in renal transplant recipients
by: W. James Chon, et al.
Published: (2016-09-01)

Detection of Cytomegalovirus in Post Hematopoietic Stem Cells Transplant Recipients by Real-Time PCR
by: Saifullah Khan Niazi, et al.
Published: (2023-10-01)

Combined detection of urine specific gravity and BK viruria on prediction of BK polyomavirus nephropathy in kidney transplant recipients
by: Xu-Tao Chen, et al.
Published: (2020-01-01)

Comparison of polyomavirus (BK virus and JC viruses) viruria in renal transplant recipients with and without kidney dysfunction
by: Shahram Taheri, et al.
Published: (2011-01-01)

Quantification of cytomegalovirus glycoprotein Bn DNA in hematopoietic stem cell transplant recipients by real-time PCR.
by: Xuan Zhang, et al.
Published: (2012-01-01)

Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
by: Susanne Jung, et al.
Published: (2019-05-01)

Proteomic analysis of urinary extracellular vesicles of kidney transplant recipients with BKV viruria and viremia: A pilot study
by: Maurizio Bruschi, et al.
Published: (2022-11-01)

Clinical significance of post-treatment viral load of cytomegalovirus in patients with hematologic malignancies
by: Wei Lu, et al.
Published: (2021-04-01)

Cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: clinical significance and definitions
by: A. A. Dmitrova, et al.
Published: (2022-06-01)

Genetic Variants Associated with Drug Resistance of Cytomegalovirus in Hematopoietic Cell Transplantation Recipients
by: Seungwan Chae, et al.
Published: (2023-05-01)

P1617: CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS DRUG RESISTANCE GENE MUTATIONS IN CYTOMEGALOVIRUS INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: D. yang, et al.
Published: (2022-06-01)

Mutations in the cytomegalovirus UL97 gene associated with ganciclovir resistance in recipients of allogeneic hematopoietic stem cell transplants
by: Demin M.V., et al.
Published: (2019-12-01)

CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS INFECTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS
by: O. M. Tsiroulnikova, et al.
Published: (2016-04-01)

Comparison of adenovirus viruria in bone marrow transplant patients before and after transplantation
by: H. Saderi, et al.
Published: (2005-01-01)

Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.
by: Euri Seo, et al.
Published: (2021-01-01)

Cytomegalovirus infection in transplant recipients
by: Luiz Sergio Azevedo, et al.
Published: (2015-07-01)

Anesthetic concerns in recipients of hematopoietic stem cell transplant
by: Sumit Roy Chowdhury, et al.
Published: (2023-01-01)

Infections in Hematopoietic Stem Cell Transplant Recipients and Prevention
by: Ayşegül YEŞİLKAYA, et al.
Published: (2006-06-01)

Correction: Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.
by: Euri Seo, et al.
Published: (2023-01-01)

Strongyloides stercoralis, Human T-cell Lymphotropic Virus Type-1 and Cytomegalovirus Coinfection in an Allogeneic Hematopoietic Stem-Cell Transplant Recipient
by: Farah Rahman, DO, et al.
Published: (2020-07-01)

Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
by: Joo Young Kim, et al.
Published: (2020-01-01)

The oncomodulatory role of human cytomegalovirus in colorectal cancer: implications for clinical trials
by: Hsin-Pai eChen, et al.
Published: (2014-11-01)

Cytomegalovirus Infection in Kidney Transplant Recipients
by: Dino Šisl, et al.
Published: (2021-04-01)

Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
by: Elena Kum, et al.
Published: (2021-01-01)

COVID-19 infection in hematopoietic stem cell transplant recipients
by: Siniaev A.A., et al.
Published: (2022-09-01)

Cytomegalovirus esophagitis with symptoms of gastroesophageal reflux disease in a kidney transplant recipient
by: Yu‐Jhou Chen, et al.
Published: (2020-10-01)

Late cytomegalovirus infection after hematopoietic stem cell transplantation: case reports
by: Samara Grapiuna Pinheiro, et al.
Published: (2013-01-01)

Metabolic Potential of the Gut Microbiome Is Significantly Impacted by Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
by: Mette Jørgensen, et al.
Published: (2022-09-01)

Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients
by: Jhong-Lin Wu, et al.
Published: (2017-06-01)

Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection
by: Kerstin M. Gergely, et al.
Published: (2021-08-01)

Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients
by: Thomas eLehrnbecher, et al.
Published: (2013-02-01)

Infections caused by Acinetobacter baumannii in recipients of hematopoietic stem cell transplantation
by: Khalid Ahmed Al-Anazi, et al.
Published: (2014-07-01)

Infections caused by Stenotrophomonas maltophilia in recipients of hematopoietic stem cell transplantation
by: Khalid Ahmed Al-Anazi, et al.
Published: (2014-08-01)

Infections Caused by Nontuberculous Mycobacteria in Recipients of Hematopoietic Stem Cell Transplantation
by: Khalid Ahmed Al-Anazi, et al.
Published: (2014-11-01)

Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation
by: Khalid Ahmed Al-Anazi, et al.
Published: (2014-08-01)

Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
by: Pascalis Vergidis, et al.
Published: (2017-03-01)

Bone and Joint Infections among Hematopoietic Stem Cell Transplant Recipients
by: C. L. Abad, et al.
Published: (2019-09-01)

Resistant cytomegalovirus infection in renal transplant recipients
by: Benjamin Pei Zhi Cherng, et al.
Published: (2015-12-01)